Aurora-B诱导着丝粒蛋白U磷酸化促进胆管癌细胞增殖的作用研究
作者:
通讯作者:
作者单位:

1.湖南省人民医院/湖南师范大学附属第一医院 肝胆外科/肝胆肿瘤研究室,湖南 长沙 410005;2.湖南省胆道疾病防治临床医学研究中心,湖南 长沙 410005

作者简介:

段小辉,湖南省人民医院主任医师,主要从事肝胆肿瘤临床及基础方面的研究。

基金项目:

湖南省自然科学基金资助项目(2018JJ3294;2019JJ80007);湖南省教育厅科学研究优青基金资助项目(20B354);湖南省教育厅科学研究重点基金资助项目(20A312);湖南省高层次卫生人才“225”工程基金资助项目。


Aurora-B promoting the proliferation of cholangiocarcinoma cells by inducing phosphorylation of centrosome protein U
Author:
Affiliation:

1.Department of Hepatobiliary Surgery/Research Laboratory of Hepatobiliary Tumor, Hunan Provincial People’s Hospital/the First-affiliated Hospital of Hunan Normal University, Changsha 410005, China;2.Clinical Medical Research Center for Biliary Disease of Hunan Province, Changsha 410005, China

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 音频文件
  • |
  • 视频文件
    摘要:

    背景与目的 有丝分裂激酶Aurora-B是胆管癌原癌基因,着丝粒蛋白U(CENPU)参与有丝分裂受Aurora-B激酶磷酸化调控,笔者团队前期在胆管癌中筛选出CENPU并证实CENPU表达水平明显高于其相应的癌旁组织,从而推测Aurora-B可能通过调控CENPU的磷酸化参与胆管癌的肿瘤生物学过程。因此,本研究探讨Aurora-B与CENPU在胆管癌中的关系及作用。方法 采用免疫组化检测10对胆管癌组织和癌旁组织中Aurora-B和CENPU以及磷酸化CENPU(p-CENPU)的表达。采用TCGA数据库的数据分析胆管癌中Aurora-B和CENPU的表达及相关性。构建Aurora-B基因敲减的胆管癌QBC939细胞系,用Western blot检测CENPU和p-CENPU的表达,CCK8法检测细胞增殖活性。构建CENPU磷酸化位点突变的胆管癌QBC939细胞系,用DMSO或Aurora-B抑制剂处理后,观察Aurora-B、CENPU和p-CENPU表达以及细胞增殖活性的变化。结果 免疫组化结果显示,胆管癌组织中Aurora-B和CENPU表达阳性率分别为22.61%和12.34%,而两者在癌旁组织中几乎无表达,同时胆管癌组织中p-CENPU的表达也明显高于癌旁组织。TCGA数据显示,胆管癌中Aurora-B和CENPU的上调(均P<0.05),且Aurora-B和CENPU的表达水平呈正相关(r=0.7322,P<0.05)。敲减Aurora-B表达后,QBC939细胞CENPU表达无明显变化,但p-CENPU表达降低、增殖活性明显减弱(P<0.05)。QBC939细胞在突变CENPU磷酸化位点或加入Aurora-B抑制剂后,前者Aurora-B表达无明显变化,后者明显降低,两者CENPU表达均无明显变化,但p-CENPU表达明显降低;突变CENPU磷酸化位点后,Aurora-B介导的QBC939细胞增殖活性较野生型明显下降(P<0.05)。结论 在胆管癌中,CENPU是Aurora-B的磷酸化底物,Aurora-B可能通过磷酸化CENPU促进胆管癌细胞的增殖。

    Abstract:

    Background and Aims The mitotic kinase Aurora-B is considered to be a proto-oncogene of cholangiocarcinoma. The action of centrosome protein U (CENPU) in mitosis is governed by phosphorylation regulation of Aurora-B kinase. The previous study conducted by the authors’ group has identified CENPU in cholangiocarcinoma and confirmed that the expression level of CENPU is significantly higher in cholangiocarcinoma tissue than that in its corresponding adjacent tissue. So, it is speculated that Aurora-B probably participates the tumor biological process of cholangiocarcinoma through regulation of the CENPU phosphorylation. Therefore, this study was performed to investigate the relationship between Aurora-B and CENPU and their effects in cholangiocarcinoma.Methods The expressions of Aurora-B and CENPU as well as the phosphorylated CENPU (p-CENPU) in 10 pairs of specimens of cholangiocarcinoma and para-carcinoma tissue were determined by immunohistochemical staining. The expressions of Aurora-B and CENPU and their correlation in cholangiocarcinoma were analyzed in TCGA database. The cholangiocarcinoma QBC939 cells with Aurora-B gene knockout were constructed, and then, the expressions of CENPU and p-CENPU were determined by Western blot analysis and the proliferative activity was detected by CCK8 assay. QBC939 cells with mutated phosphorylation site of CENPU were constructed, in which, the changes in expressions of Aurora-B, CENPU and p-CENPU as well as the proliferation activity were observed.Results The results of immunohistochemical staining showed that positive expression rates of Aurora-B and CENPU in cholangiocarcinoma tissue were 22.61% and 12.34%, respectively, but nearly none of them expressed in adjacent tissue. Meanwhile, the expression level of p-CENPU in cholangiocarcinoma tissue was remarkably higher than that in adjacent tissue. TCGA data showed that both expressions of Aurora-B and CENPU were up-regulated in cholangiocarcinoma (both P<0.05), and there was a positive correlation between the expressions of Aurora-B and CENPU (r=0.7322, P<0.05). In QBC939 cells after knockdown of Aurora-B expression, there was no significant change in CENPU expression, but the p-CENPU expression was down-regulated, and the proliferation activity was significantly decreased (P<0.05). In QBC939 cells after mutating the phosphorylation site of CENPU or adding Aurora-B inhibitor, Aurora-B expression showed no change in the former, but was significantly reduced in the latter, and in both conditions, the CENPU expressions showed no changes, but the p-CENPU expressions were decreased; after mutating the phosphorylation site of CENPU, the proliferation activity of QBC939 cells mediated by Aurora-B was significantly lower than that of the wild-type (P<0.05).Conclusion CENPU is the phosphorylation substrate of Aurora-B in cholangiocarcinoma cells. Aurora-B promotes the proliferation of cholangiocarcinoma cells probably by phosphorylation of CENPU.

    图1 Aurora-B与CENPU的免疫组化检测 A:Aurora-B与CENPU在胆管癌组织与癌旁组织中的表达(×400);B:p-CENPU在胆管癌组织与癌旁组织中的表达Fig.1 Immunohistochemical staining for Aurora-B and CENPU A: Expressions of Aurora-B and CENPU in cholangiocarcinoma and adjacent tissues (×400); B: Expressions of p-CENPU in cholangiocarcinoma and adjacent tissues
    图2 TCGA数据库中分析 A-B:Aurora-B(AURKB)与CENPU在胆管癌组织中的表达高于癌旁正常组织;C:胆管癌组织中CENPU与Aurora-B的表达呈正相关Fig.2 TCGA database analysis A-B: Higher expressions of Aurora-B (AURKB) and CENPU in cholangiocarcinoma tissue than normal adjacent tissue; C: A positive correlation between CENPU and Aurora-B expressions in cholangiocarcinoma
    图3 QBC939细胞Aurora-B敲减实验 A:qRT-PCR检测3个shRNA的敲除效率;B:CCK8法检测Aurora-B基因敲减对QBC939细胞增殖的影响;C:Western blot法检测Aurora-B基因敲减对QBC939细胞CENPU和p-CENPU表达的影响Fig.3 Experiment of Aurora-B knockdown in QBC939 cells A: The knockdown efficiencies of 3 shRNAs evaluated by qRT-PCR; B: Influence of Aurora-B knockdown on proliferation of QBC939 cells detected by CCK8 assay; C: Influence of Aurora-B knockdown on expressions of CENPU and p-CENPU of QBC939 cells determined by Western blot analysis
    图4 QBC939细胞CENPU磷酸化位点突变与Aurora-B抑制剂作用实验 A:荧光成像技术检测对照组、CENPU-WT组和CENPU-MUT组慢病毒转染效率(×200);B:DMSO或Aurora-B抑制剂处理后,在有或无CENPU磷酸化位点突变的QBC939细胞中Aurora-B、CENPU和p-CENPU的表达;C:CCK8检测有或无CENPU磷酸化位点突变的QBC939细胞的增殖Fig.4 Experiments of phosphorylation site mutation of CENPU and Aurora-B inhibitor treatment in QBC939 cells A: Fluorescence imaging assessment of the lentivirus transfection efficiencies in control, CENPU-WT and CENPU-MUT groups (×200); B: The expressions of Aurora-B, CENPU and p-CENPU in QBC939 cells with or without phosphorylation site mutation of CENPU treated with DMSO or Aurora-B inhibitor; C: CCK8 assay for proliferation abilities of QBC939 cells with or without phosphorylation site mutation of CENPU
    参考文献
    相似文献
    引证文献
引用本文

段小辉,申瑶,黄靖波,刘亚晖,毛先海. Aurora-B诱导着丝粒蛋白U磷酸化促进胆管癌细胞增殖的作用研究[J].中国普通外科杂志,2021,30(8):909-916.
DOI:10.7659/j. issn.1005-6947.2021.08.005

复制
分享
文章指标
  • 点击次数:
  • 下载次数:
历史
  • 收稿日期:2021-06-30
  • 最后修改日期:2021-07-25
  • 录用日期:
  • 在线发布日期: 2021-09-02